STOCK TITAN
  1. Home
  2. News
  3. VAXX

Vaxxinity Inc - VAXX STOCK NEWS

IMPACT
SENTIMENT
VAXX : Nasdaq
Vaxxinity to Present at Upcoming November Medical and Investor Conferences
conferences
IMPACT
SENTIMENT
VAXX : Nasdaq
Vaxxinity Reports Third Quarter 2023 Financial Results and Provides Corporate Update
earnings
IMPACT
SENTIMENT
VAXX : Nasdaq
Vaxxinity to Present at Upcoming Investor Conferences in September
conferences
IMPACT
SENTIMENT
VAXX : Nasdaq
Vaxxinity Announces Publication of UB-311 Safety, Tolerability, Immunogenicity, and Clinical Efficacy Data from Phase 2a Trial in Alzheimer’s Disease
clinical trial
IMPACT
SENTIMENT
VAXX : Nasdaq
Vaxxinity Reports Second Quarter 2023 Financial Results and Provides Corporate Update
earnings
IMPACT
SENTIMENT
VAXX : Nasdaq
Vaxxinity Appoints Peter Powchik, M.D., to Executive Vice President, Global Scientific Director
management
IMPACT
SENTIMENT
VAXX : Nasdaq
Vaxxinity Demonstrates Target Engagement of Toxic Alpha-Synuclein in Parkinson’s Patients
IMPACT
SENTIMENT
VAXX : Nasdaq
Vaxxinity Announces UB-312 Successfully Met Primary Objectives of Phase 1 Clinical Trial in Parkinson’s Disease
clinical trial
IMPACT
SENTIMENT
VAXX : Nasdaq
Vaxxinity Reports First Quarter 2023 Financial Results and Provides Corporate Update
earnings
IMPACT
SENTIMENT
VAXX : Nasdaq
Vaxxinity to Present at World Vaccine Congress, American Academy of Neurology, and BNA2023 Festival of Neuroscience in April
conferences
Stock VAXX logo
Vaxxinity Inc

Nasdaq:VAXX

VAXX Rankings

#5136 Ranked by Market Cap
#3651 Ranked by Stock Gains
N/A Ranked by Dividends

VAXX Stock Data

Research and Development in Biotechnology
Professional, Scientific, and Technical Services
Link
United States
Merritt Island

About VAXX

vaccines against chronic diseases